Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RBM20 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | BIRC3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | MMP8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PIF1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | C11orf57 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | FAM160A2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ESRP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | NOTCH1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | ACRBP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | SPATA3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |